- 专利标题: Compounds for the treatment of hepatitis C
-
申请号: US12045766申请日: 2008-03-11
-
公开(公告)号: US07521444B2公开(公告)日: 2009-04-21
- 发明人: John A. Bender , Robert G. Gentles , Ying Han , Yong Tu , Zhong Yang , Kap-Sun Yeung , Katharine A. Grant-Young
- 申请人: John A. Bender , Robert G. Gentles , Ying Han , Yong Tu , Zhong Yang , Kap-Sun Yeung , Katharine A. Grant-Young
- 申请人地址: US NJ Princeton
- 专利权人: Bristol-Myers Squibb Company
- 当前专利权人: Bristol-Myers Squibb Company
- 当前专利权人地址: US NJ Princeton
- 代理商 James Epperson
- 主分类号: A61P31/00
- IPC分类号: A61P31/00 ; A61K31/55 ; C07D223/14
摘要:
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
公开/授权文献
- US20080226590A1 Compounds for the Treatment of Hepatitis C 公开/授权日:2008-09-18